-
1
-
-
85030817582
-
-
S-Africa Patent 6,801,724, 1968;
-
(a) Meltesics, W.; Sternbach, L. H. S-Africa Patent 6,801,724, 1968; Chem. Abstr., 1969, 71, 61384r.
-
(1969)
Chem. Abstr.
, vol.71
-
-
Meltesics, W.1
Sternbach, L.H.2
-
2
-
-
14344264936
-
-
U.S. Patent 3,905,994, 1975;
-
(b) Meltesics, W.; Sternbach, L. H. U.S. Patent 3,905,994, 1975; Chem. Abstr., 1976, 84, 17346z.
-
(1976)
Chem. Abstr.
, vol.84
-
-
Meltesics, W.1
Sternbach, L.H.2
-
3
-
-
85030808496
-
-
U.S. Patent 3,929,766, 1975;
-
(c) Meltesics, W.; Sternbach, L. H. U.S. Patent 3,929,766, 1975; Chem. Abstr., 1976, 84, 105599q.
-
(1976)
Chem. Abstr.
, vol.84
-
-
Meltesics, W.1
Sternbach, L.H.2
-
4
-
-
14344256187
-
-
Neth Patent Appl., 6,613,264, 1967;
-
Geigy, J. R.; Neth Patent Appl., 6,613,264, 1967; Chem. Abstr., 1967, 67, 82204q.
-
(1967)
Chem. Abstr.
, vol.67
-
-
Geigy, J.R.1
-
5
-
-
4243246410
-
-
Swiss Patent 4,82,697, 1970;
-
Graf, W., Swiss Patent 4,82,697, 1970; Chem. Abstr., 1970, 73, 25474c.
-
(1970)
Chem. Abstr.
, vol.73
-
-
Graf, W.1
-
6
-
-
0016440713
-
-
P. Aeberli, P. Eden, J.H. Gogerty, W.J. Houlihan, and C. Penberthy J. Med. Chem. 18 1975 177
-
(1975)
J. Med. Chem.
, vol.18
, pp. 177
-
-
Aeberli, P.1
Eden, P.2
Gogerty, J.H.3
Houlihan, W.J.4
Penberthy, C.5
-
7
-
-
0016433797
-
-
P. Aeberli, P. Eden, J.H. Gogerty, W.J. Houlihan, and C. Penberthy J. Med. Chem. 18 1975 182
-
(1975)
J. Med. Chem.
, vol.18
, pp. 182
-
-
Aeberli, P.1
Eden, P.2
Gogerty, J.H.3
Houlihan, W.J.4
Penberthy, C.5
-
8
-
-
4244217554
-
-
U.S. Patent 3,663,532, 1972;
-
(c) Sulkowski, T. S. U.S. Patent 3,663,532, 1972; Chem. Abstr., 1972, 77, 88559n.
-
(1972)
Chem. Abstr.
, vol.77
-
-
Sulkowski, T.S.1
-
9
-
-
84861587223
-
-
U.S. Patent 3,994,920, 1976;
-
(d) Sulkowski, T. S., U.S. Patent 3,994,920, 1976; Chem. Abstr., 1977, 86, 106681p
-
(1977)
Chem. Abstr.
, vol.86
-
-
Sulkowski, T.S.1
-
10
-
-
8644256349
-
-
U.S. Patent 3,763,178, 1974;
-
Sulkowski, T. S. U.S. Patent 3,763,178, 1974; Chem. Abstr., 1974, 80, 3547w.
-
(1974)
Chem. Abstr.
, vol.80
-
-
Sulkowski, T.S.1
-
11
-
-
0011313503
-
-
U.S. Patent 4,093,441, 1978;
-
Ashkar, S. A. U.S. Patent 4,093,441, 1978; Chem. Abstr., 1979, 90, 49647p.
-
(1979)
Chem. Abstr.
, vol.90
-
-
Ashkar, S.A.1
-
12
-
-
85030810355
-
-
U.S. Patent 4,401,045, 1977;
-
(a) Los, M. U.S. Patent 4,401,045, 1977; Chem. Abstr., 1977, 87, 18034j.
-
(1977)
Chem. Abstr.
, vol.87
-
-
Los, M.1
-
13
-
-
4243880455
-
-
Ger-Offen. Patent 2,700,269, 1977;
-
(b) Los, M., Ger-Offen. Patent 2,700,269, 1977; Chem. Abstr., 1978, 89, 146905h.
-
(1978)
Chem. Abstr.
, vol.89
-
-
Los, M.1
-
14
-
-
4243563113
-
-
U.S. Patent 4,067,718, 1978;
-
(c) Ashkar, S. A. U.S. Patent 4,067,718, 1978; Chem. Abstr., 1978, 88, 165485s.
-
(1978)
Chem. Abstr.
, vol.88
-
-
Ashkar, S.A.1
-
15
-
-
4243898888
-
-
U.S. Patent 4,090,860, 1978;
-
(d) Ashkar, S. A. U.S. Patent 4,090,860, 1978; Chem. Abstr., 1978, 89, 192503y
-
(1978)
Chem. Abstr.
, vol.89
-
-
Ashkar, S.A.1
-
16
-
-
0023792849
-
-
Batracylin is an experimental anti-tumor agent which is active as a topoisomerase II inhibitor and induces unscheduled DNA synthesis in nonproliferating cells. For this subject see the following references: (a) J. Plowmann, K.D. Paull, G. Atassi, S.D. Harrison, D.J. Dykes, Y.L. Narayanan, and O.L. Yoder Invest. New. Drugs 6 1988 147
-
(1988)
Invest. New. Drugs
, vol.6
, pp. 147
-
-
Plowmann, J.1
Paull, K.D.2
Atassi, G.3
Harrison, S.D.4
Dykes, D.J.5
Narayanan, Y.L.6
Yoder, O.L.7
-
17
-
-
0025976393
-
-
W.R. Wand, S.D. Harrison, K.S. Gilbert, W.R. Laster, and D.P. Griswold Cancer Chemother. Pharmacol. 27 1991 456
-
(1991)
Cancer Chemother. Pharmacol.
, vol.27
, pp. 456
-
-
Wand, W.R.1
Harrison, S.D.2
Gilbert, K.S.3
Laster, W.R.4
Griswold, D.P.5
-
18
-
-
0028097507
-
-
S.K. Meegalla, G.J. Stevens, C.A. McQueen, A.Y. Chen, C. Yu, L.F. Liu, L.R. Barrows, and E.J. LaVoie J. Med. Chem. 37 1994 3434
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3434
-
-
Meegalla, S.K.1
Stevens, G.J.2
McQueen, C.A.3
Chen, A.Y.4
Yu, C.5
Liu, L.F.6
Barrows, L.R.7
Lavoie, E.J.8
-
22
-
-
0342759860
-
-
A.E. Szabó, G. Stájer, P. Sohár, R. Sillanpää, and G. Bernáth Acta Chem. Scand. 49 1995 751
-
(1995)
Acta Chem. Scand.
, vol.49
, pp. 751
-
-
Szabó, A.E.1
Stájer, G.2
Sohár, P.3
Sillanpää, R.4
Bernáth, G.5
-
23
-
-
0042455453
-
-
P. Sohár, G. Stájer, A.E. Szabó, J. Szúnyog, and G. Bernáth Heterocycles 48 1993 175
-
(1993)
Heterocycles
, vol.48
, pp. 175
-
-
Sohár, P.1
Stájer, G.2
Szabó, A.E.3
Szúnyog, J.4
Bernáth, G.5
-
24
-
-
85030812946
-
-
(a) See Ref. 4a.
-
(a) See Ref. 4a.
-
-
-
-
25
-
-
0010196528
-
-
J.W. Barton, M.C. Goodland, K.-J. Gould, J.F.W. McOmie, W.R. Mound, and S.A. Saleh Tetrahedron 35 1979 241
-
(1979)
Tetrahedron
, vol.35
, pp. 241
-
-
Barton, J.W.1
Goodland, M.C.2
Gould, K.-J.3
McOmie, J.F.W.4
Mound, W.R.5
Saleh, S.A.6
-
26
-
-
0024586855
-
-
A. Chimirri, A. De Sarro, G. De Sarro, S. Grasso, G.R. Trimarchi, and M. Zappalà J. Med. Chem. 32 1989 93
-
(1989)
J. Med. Chem.
, vol.32
, pp. 93
-
-
Chimirri, A.1
De Sarro, A.2
De Sarro, G.3
Grasso, S.4
Trimarchi, G.R.5
Zappalà, M.6
-
28
-
-
0035513109
-
-
A. Chimirri, A. De Sarro, G. De Sarro, R. Gitto, and M. Zappalà Il Farmaco 56 2001 821
-
(2001)
Il Farmaco
, vol.56
, pp. 821
-
-
Chimirri, A.1
De Sarro, A.2
De Sarro, G.3
Gitto, R.4
Zappalà, M.5
-
33
-
-
0034741374
-
-
A.R. Katritzky, Y.-J. Xu, H.-Y. He, and P.J. Steel J. Chem. Soc., Perkin Trans. 1 2001 1767
-
(2001)
J. Chem. Soc., Perkin Trans. 1
, pp. 1767
-
-
Katritzky, A.R.1
Xu, Y.-J.2
He, H.-Y.3
Steel, P.J.4
-
46
-
-
85030813821
-
-
note
-
Efforts to prepare 5a,b by reaction of phthalic anhydride (1) with amines 2a,b under classical azeotropic removal of water with or without base as catalyst were unsuccessful. Only a complex mixture was obtained in all attempts.
-
-
-
-
48
-
-
85030812431
-
-
note
-
The reaction was not performed under inert atmosphere, consequently the evoked spontaneous oxidation was caused probably by the air present in the system.
-
-
-
-
49
-
-
85030807565
-
-
note
-
For a recent use of this methodology, see Ref. 11e.
-
-
-
-
50
-
-
0028946745
-
-
For the reaction between various substituted phenylene-diamine and 2-formylbenzoic acid (2) and the orientation role of the benzene substituent in the process, see the following references: (a) J.A. Hadfield, V.H. Pavlidis, and J.R.A. Roffey Synth. Commun. 25 1995 1319
-
(1995)
Synth. Commun.
, vol.25
, pp. 1319
-
-
Hadfield, J.A.1
Pavlidis, V.H.2
Roffey, J.R.A.3
-
51
-
-
85030807864
-
-
(b) see Ref. 11c.
-
(b) see Ref. 11c.
-
-
-
-
52
-
-
33947306618
-
-
25b rings, no oxidation process was observed and the N,N-aminal components were isolated in good yields. For this end, see respectively: (a) W. Metlesics, T. Anton, M. Chaykovsky, V. Toome, and L.H. Sternbach J. Org. Chem. 33 1968 2874
-
(1968)
J. Org. Chem.
, vol.33
, pp. 2874
-
-
Metlesics, W.1
Anton, T.2
Chaykovsky, M.3
Toome, V.4
Sternbach, L.H.5
-
53
-
-
0042455453
-
-
P. Sohár, G. Stájer, A.E. Szabó, J. Szúnyog, and G. Bernáth Heterocycles 48 1998 175
-
(1998)
Heterocycles
, vol.48
, pp. 175
-
-
Sohár, P.1
Stájer, G.2
Szabó, A.E.3
Szúnyog, J.4
Bernáth, G.5
-
56
-
-
0037184882
-
-
For a recent example in this area, see: S.M. Allin, S.L. James, R.J. Elsegood, and W.P. Martin J. Org. Chem. 67 2002 9464
-
(2002)
J. Org. Chem.
, vol.67
, pp. 9464
-
-
Allin, S.M.1
James, S.L.2
Elsegood, R.J.3
Martin, W.P.4
-
57
-
-
85030812174
-
-
note
-
2/hexane (9/1) as eluent.
-
-
-
-
58
-
-
0030743362
-
-
For the sole work using a pyridine ring as internal α-aromatic nucleophile in π-amidoalkylation process, see: M.A. Brodney, and A. Padwa Tetrahedron Lett. 38 1997 6153
-
(1997)
Tetrahedron Lett.
, vol.38
, pp. 6153
-
-
Brodney, M.A.1
Padwa, A.2
-
59
-
-
0001174915
-
-
For a catalytic hydrogenolysis deprotection of the N-benzyl[1,4]diazepine derivative 15 into isoindolo[1,4]-diazepine 14b, see: G.N. Walker, A.R. Engle, and R.J. Kempton J. Org. Chem. 37 1972 3755
-
(1972)
J. Org. Chem.
, vol.37
, pp. 3755
-
-
Walker, G.N.1
Engle, A.R.2
Kempton, R.J.3
|